Abstract
We have developed a new idea to synthesize key intermediate molecule by utilizing deep eutectic solvent (DES) and ultrasound in a multistep reaction to ensure process cost-effective. Key intermediate (3) and final compounds (4a–n) were synthesized in a higher yield of 95% and 80–88% respectively. Further, final compounds (4a–n) were assessed for their anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation. The compounds 4f, 4g, 4j, 4l, and 4m showed good anti-inflammatory activity, while 4f, 4i, and 4n exhibited very good analgesic activity as compared to the standard drug. The ulcerogenicity of selected compounds was far less than the indomethacin. The ligands had also shown a good docking score (4f = −6.859 and 4n = −7.077) as compared to control indomethacin (−6.109).State-of-art DFT theory was used to validate the lipid peroxidation mechanism of the active compounds which was in good agreement with the variations of BDEs and IP of the tested compounds.
Highlights
Non-steroidal anti-inflammatory drugs (NSAIDs) are a profound application for the treatment of inflammatory diseases and pain
This section may be divided by subheadings
We have examined the lipid peroxidation (LP) of compounds which exhibited maximum anti-inflammatory and analgesic activities (4c, 4f, 4i, 4n)
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) are a profound application for the treatment of inflammatory diseases and pain. The COX-2 is an inducible enzyme that works through the mediation of the selective inflammatory signal and the therapeutic anti-inflammatory action of NSAIDs is produced by the inhibition of COX-2 [10,11,12,13,14] Based on this observation, many selective COX-2 inhibitors like celecoxib, rofecoxib, and valdecoxib emerged as relatively safe NSAID'S together with improved gastric problems. The reporting of the cardiovascular side effects, for example, increased risk of myocardial infarction, stroke, heart failure and hypertension caused the withdrawal of many COX-2 inhibitors from the market [15] This encouraged research professional to develop newer chemical entities as anti-inflammatory agents with minimal side effects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.